Smart microneedle coatings for controlled delivery and biomedical analysis
Journal of Drug Targeting
|June 4, 2014
Summary
Researchers developed smart microneedle (MN) coatings using electrohydrodynamic atomisation (EHDA). This novel method precisely deposits nano- and micro-scale drug particles and fibers onto MNs for advanced drug delivery and diagnostics.
Area of Science:
- Materials Science
- Biomedical Engineering
- Nanotechnology
Background:
- Microneedles (MNs) offer minimally invasive drug delivery and diagnostics.
- Developing precise and scalable methods for MN coating is crucial for advanced applications.
Purpose of the Study:
- To demonstrate an unconventional approach for preparing smart microneedle (MN) coatings using electrohydrodynamic atomisation (EHDA).
- To achieve controlled deposition of nano- and micro-scale pharmaceutical coatings directly onto MNs.
Main Methods:
- Utilised stainless steel MNs coupled to a ground electrode in an EHDA setup.
- Varied deposition distance and collection methodology with an ethanol:methanol vehicle system.
- Formulated coatings with fluorescein dye and polyvinylpyrrolidone (PVP), controlling particle and fiber sizes via flow rates (5-50 µL/min) and applied voltage (6-19 kV).
Main Results:
- Successfully prepared nano- (100 nm) and micro- (up to 3 µm) scale particles and micro-scale fibers (400 nm to 1 µm) directly on MNs.
- Demonstrated controlled and selectable deposition of coating materials.
- EHDA process enabled room temperature fabrication with controlled output.
Conclusions:
- EHDA is a viable and unconventional method for fabricating smart MN coatings.
- The developed technique offers potential for multiple targeting and analysis applications.
- EHDA process shows significant scale-up potential for emerging MN drug delivery systems and lab-chip testing devices.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
159
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
159
Modified-Release Drug Delivery Systems: Site-Targeted
161
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
161


